Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design. (2018)

First Author: Viegas EO
Attributed to:  Prevention Programme - Microbicides. funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0206838

PubMed Identifier: 30496299

Publication URI: http://europepmc.org/abstract/MED/30496299

Type: Journal Article/Review

Volume: 13

Parent Publication: PloS one

Issue: 11

ISSN: 1932-6203